Want to see HK:8156 full AI Analyst Report?

Sinopharm Tech Holdings Limited (8156) Ratios

0 Followers

Sinopharm Tech Holdings Limited Ratios

HK:8156's free cash flow for Q3 2025 was HK$0.06. For the 2025 fiscal year, HK:8156's free cash flow was decreased by HK$ and operating cash flow was HK$-0.35. See a summary of the company’s cash flow.

Ratios	TTM	Jun 25	Jun 24	Jun 23	Jun 22
Liquidity Ratios
Current Ratio	―	0.38	0.72	0.15	0.13
Quick Ratio	―	0.38	0.52	0.14	0.12
Cash Ratio	―	0.10	0.10	0.01	<0.01
Solvency Ratio	―	-0.11	<0.01	-0.07	-0.04
Operating Cash Flow Ratio	―	-0.07	-0.11	-0.04	0.02
Short-Term Operating Cash Flow Coverage	―	-0.27	-0.27	-0.13	0.09
Net Current Asset Value	HK$ ―	HK$ -50.35M	HK$ -39.30M	HK$ -212.02M	HK$ -186.19M
Leverage Ratios
Debt-to-Assets Ratio	―	1.37	0.90	1.65	1.58
Debt-to-Equity Ratio	―	-0.66	-1.27	-0.37	-0.31
Debt-to-Capital Ratio	―	-1.96	4.74	-0.58	-0.44
Long-Term Debt-to-Capital Ratio	―	-0.52	0.00	0.00	0.00
Financial Leverage Ratio	―	-0.48	-1.40	-0.22	-0.19
Debt Service Coverage Ratio	―	-0.48	0.18	0.05	<0.01
Interest Coverage Ratio	―	0.00	-1.22	-0.38	-10.59
Debt to Market Cap	―	0.33	0.31	3.56	0.83
Interest Debt Per Share	―	0.07	0.11	0.53	0.34
Net Debt to EBITDA	―	-3.62	6.51	14.18	-50.46
Profitability Margins
Gross Profit Margin	―	14.09%	22.06%	12.16%	12.77%
EBIT Margin	―	-17.91%	7.80%	8.72%	-7.05%
EBITDA Margin	―	-15.22%	9.97%	12.06%	-2.37%
Operating Profit Margin	―	-17.91%	-11.64%	-22.20%	-211.91%
Pretax Profit Margin	―	-25.65%	-1.76%	-49.26%	-25.33%
Net Profit Margin	―	-20.06%	-1.42%	-47.72%	-24.83%
Continuous Operations Profit Margin	―	-26.11%	-2.24%	-49.46%	-22.27%
Net Income Per EBT	―	78.20%	80.35%	96.88%	98.03%
EBT Per EBIT	―	143.15%	15.14%	221.89%	11.95%
Return on Assets (ROA)	―	-40.74%	-1.68%	-44.28%	-31.76%
Return on Equity (ROE)	―	19.70%	2.35%	9.87%	6.16%
Return on Capital Employed (ROCE)	―	24.78%	42.84%	4.47%	50.50%
Return on Invested Capital (ROIC)	―	44.99%	-71.00%	6.92%	62.99%
Return on Tangible Assets	―	-40.74%	-1.68%	-44.28%	-31.76%
Earnings Yield	―	-9.70%	-1.01%	-97.48%	-16.62%
Efficiency Ratios
Receivables Turnover	―	7.98	2.32	1.45	1.87
Payables Turnover	―	4.27	2.08	1.12	1.07
Inventory Turnover	―	331.87	3.54	10.25	43.71
Fixed Asset Turnover	―	30.92	23.53	10.63	36.83
Asset Turnover	―	2.03	1.18	0.93	1.28
Working Capital Turnover Ratio	―	-1.70	-0.53	-0.21	-0.22
Cash Conversion Cycle	―	-38.54	85.21	-38.99	-137.49
Days of Sales Outstanding	―	45.76	157.56	252.51	195.35
Days of Inventory Outstanding	―	1.10	103.07	35.61	8.35
Days of Payables Outstanding	―	85.40	175.43	327.11	341.20
Operating Cycle	―	46.86	260.63	288.12	203.70
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	-0.02	-0.05	0.03
Free Cash Flow Per Share	―	>-0.01	-0.02	-0.07	0.03
CapEx Per Share	―	0.00	0.00	0.02	0.00
Free Cash Flow to Operating Cash Flow	―	1.00	1.00	1.36	1.00
Dividend Paid and CapEx Coverage Ratio	―	0.00	0.00	-2.78	0.00
Capital Expenditure Coverage Ratio	―	0.00	0.00	-2.78	0.00
Operating Cash Flow Coverage Ratio	―	-0.13	-0.15	-0.13	0.09
Operating Cash Flow to Sales Ratio	―	-0.09	-0.12	-0.22	0.11
Free Cash Flow Yield	―	-4.27%	-8.38%	-62.26%	7.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-10.30	-97.37	-1.03	-6.02
Price-to-Sales (P/S) Ratio	―	2.07	1.40	0.49	1.49
Price-to-Book (P/B) Ratio	―	-2.03	-2.33	-0.10	-0.37
Price-to-Free Cash Flow (P/FCF) Ratio	―	-23.42	-11.93	-1.61	13.52
Price-to-Operating Cash Flow Ratio	―	-23.42	-11.93	-2.18	13.52
Price-to-Earnings Growth (PEG) Ratio	―	-0.01	0.99	-0.01	0.07
Enterprise Value Multiple	―	-17.20	20.59	18.24	-113.52
Enterprise Value	―	119.32M	125.77M	90.82M	115.23M
EV to EBITDA	―	-17.20	20.59	18.24	-113.52
EV to Sales	―	2.62	2.05	2.20	2.69
EV to Free Cash Flow	―	-29.67	-17.45	-7.22	24.35
EV to Operating Cash Flow	―	-29.67	-17.45	-9.82	24.35
Tangible Book Value Per Share	―	-0.11	-0.08	-1.12	-0.98
Shareholders’ Equity Per Share	―	-0.10	-0.08	-1.09	-0.94
Tax and Other Ratios
Effective Tax Rate	―	-0.02	-0.27	>-0.01	0.12
Revenue Per Share	―	0.10	0.13	0.22	0.23
Net Income Per Share	―	-0.02	>-0.01	-0.11	-0.06
Tax Burden	―	0.78	0.80	0.97	0.98
Interest Burden	―	1.43	-0.23	-5.65	3.59
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.32	0.34	0.33	0.46
Stock-Based Compensation to Revenue	―	0.00	0.00	0.02	0.06
Income Quality	―	0.44	8.31	0.46	-0.41

Currency in HKD